Polysaccharide capsule export in the fungal pathogen Cryptococcus neoformans
Polysaccharide capsule export in the fungal pathogen Cryptococcus neoformans
批准号:
7239830
负责人:
Tamara L Doering
金额:
$22.18万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-20 至 2009-08-31
关键词:
Acquired Immunodeficiency SyndromeAddressAnabolismAreaBasic ScienceBiochemicalBiologicalBiological AssayBiological ModelsBiologyCarbohydratesCell FractionationCell WallCell surfaceCellsCellular biologyChromatographyConditionCryptococcusCryptococcus neoformansDiseaseElectronsEngineeringEnzymesGoalsHumanImmunocompromised HostIndividualInfectionInvestigationKnowledgeLeftLifeMethodsMicrobeNatureOrganismPathogenesisPolysaccharidesPrecipitationProcessPublic HealthResearchRouteSecretory VesiclesStructureSurfaceTravelVesicleVirulence FactorsWorkabstractinganalytical methodcapsuledesignexperiencefascinatefungusmutantnovel strategiespathogenresearch studysize
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Polysaccharide Capsule Export in the Fungal Pathogen Cryptococcus neoformans ABSTRACT Cryptococcus neoformans is an opportunistic pathogen, responsible for life-threatening disease in individuals who are immunocompromised due to AIDS or other conditions. The main virulence factor of Cryptococcus is an extensive polysaccharide capsule that surrounds its cell wall. This capsule is required for the fungus to cause disease. Little information is available about the intracellular formation of capsule components, and none about how they exit the cell and become associated with its surface. In this R21 application we propose to develop new approaches to exploration of these fundamental questions, using cell biological methods that have not yet been applied to C. neoformans. Specifically, we propose to directly investigate the nature of intracellular capsular material, taking advantage of a mutant strain we have engineered to accumulate secretory vesicles containing capsule- related polysaccharides. Aim I proposes to develop methods to purify and characterize the secretory vesicles that contain capsule precursors. Aim II proposes to isolate capsule-related polysaccharides from these vesicles, purify them, and apply analytical methods to define their glycan structures. Depending on the specific nature of the capsule precursors, the experiments may begin to address the presence of any non-carbohydrate components associated with the relevant glycans. The approaches that will be used to achieve these goals include subcellular fractionation, electron micros- copy, biochemical enzyme assays, immuno-detection, differential extraction and precipitation, a variety of chromatography methods, and glycan analysis. These exploratory studies will have a major impact on the field, as they will address a critical gap in our understanding of this organism's major virulence factor, break new ground in the methods available for study of C. neoformans, and open exciting areas for investigation of this important pathogen. / RELEVANCE This research is highly relevant to public health because the organism being investigated causes serious human illness, for which current therapies are not adequate. The process to be studied is fundamental to the ability of Cryptococcus neoformans to cause disease, so understanding and inhibiting it may advance treatment of cryptococcal infection. Further, this work will contribute to basic science knowledge, which will impact the area of pathogenic microbes as well as other areas of biology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Filling gaps in the cryptococcal wall with glycogen and a novel enzyme
-
批准号:10648839
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2023
-
负责人:Tamara L Doering
-
依托单位:
Leveraging genomic approaches to define sterol transport in Cryptococcus neoformans
-
批准号:10727128
-
项目类别:
-
资助金额:$19.48万
-
财政年份:2023
-
负责人:Tamara L Doering
-
依托单位:
Natural genomic variants that influence cryptococcal pathogenicity
-
批准号:10647845
-
项目类别:
-
资助金额:$59.37万
-
财政年份:2020
-
负责人:Tamara L Doering
-
依托单位:
Natural genomic variants that influence cryptococcal pathogenicity
-
批准号:10437750
-
项目类别:
-
资助金额:$59.04万
-
财政年份:2020
-
负责人:Tamara L Doering
-
依托单位:
Natural genomic variants that influence cryptococcal pathogenicity
-
批准号:10206032
-
项目类别:
-
资助金额:$61.22万
-
财政年份:2020
-
负责人:Tamara L Doering
-
依托单位:
CRYPTOCOCCAL GLYCAN SYNTHESIS
-
批准号:9927569
-
项目类别:
-
资助金额:$51.41万
-
财政年份:2018
-
负责人:Tamara L Doering
-
依托单位:
CRYPTOCOCCAL GLYCAN SYNTHESIS
-
批准号:10153676
-
项目类别:
-
资助金额:$49.09万
-
财政年份:2018
-
负责人:Tamara L Doering
-
依托单位:
CRYPTOCOCCAL GLYCAN SYNTHESIS
-
批准号:10406884
-
项目类别:
-
资助金额:$47.06万
-
财政年份:2018
-
负责人:Tamara L Doering
-
依托单位:
GLYCAN PRECURSOR TRANSPORT IN CRYPTOCOCCUS NEOFORMANS
-
批准号:8823633
-
项目类别:
-
资助金额:$19.06万
-
财政年份:2014
-
负责人:Tamara L Doering
-
依托单位:
GLYCAN PRECURSOR TRANSPORT IN CRYPTOCOCCUS NEOFORMANS
-
批准号:8709197
-
项目类别:
-
资助金额:$22.85万
-
财政年份:2014
-
负责人:Tamara L Doering
-
依托单位:
HOST FACTORS IN CRYPTOCOCCAL PATHOGENESIS
-
批准号:9284385
-
项目类别:
-
资助金额:$40.87万
-
财政年份:2013
-
负责人:Tamara L Doering
-
依托单位:
HOST FACTORS IN CRYPTOCOCCAL PATHOGENESIS
-
批准号:8848028
-
项目类别:
-
资助金额:$44.28万
-
财政年份:2013
-
负责人:Tamara L Doering
-
依托单位:
HOST FACTORS IN CRYPTOCOCCAL PATHOGENESIS
-
批准号:8677686
-
项目类别:
-
资助金额:$48.12万
-
财政年份:2013
-
负责人:Tamara L Doering
-
依托单位:
HOST FACTORS IN CRYPTOCOCCAL PATHOGENESIS
-
批准号:8610782
-
项目类别:
-
资助金额:$39.32万
-
财政年份:2013
-
负责人:Tamara L Doering
-
依托单位:
A NOVEL GLYCAN SYNTHETIC ACTIVITY IN CRYPTOCOCCUS NEOFORMANS
-
批准号:8020009
-
项目类别:
-
资助金额:$18.81万
-
财政年份:2010
-
负责人:Tamara L Doering
-
依托单位:
A NOVEL GLYCAN SYNTHETIC ACTIVITY IN CRYPTOCOCCUS NEOFORMANS
-
批准号:7798321
-
项目类别:
-
资助金额:$22.8万
-
财政年份:2010
-
负责人:Tamara L Doering
-
依托单位:
HOST FACTORS IN CRYPTOCOCCAL INFECTION
-
批准号:7772248
-
项目类别:
-
资助金额:$22.57万
-
财政年份:2009
-
负责人:Tamara L Doering
-
依托单位:
CRYPTOCOCCAL INTERACTIONS WITH HOST CELLS
-
批准号:7683612
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2009
-
负责人:Tamara L Doering
-
依托单位:
CRYPTOCOCCAL INTERACTIONS WITH HOST CELLS
-
批准号:8215680
-
项目类别:
-
资助金额:$37.24万
-
财政年份:2009
-
负责人:Tamara L Doering
-
依托单位:
CRYPTOCOCCAL INTERACTIONS WITH HOST CELLS
-
批准号:8498666
-
项目类别:
-
资助金额:$4.91万
-
财政年份:2009
-
负责人:Tamara L Doering
-
依托单位:
海外基金